Revolving Door: DEA’s No.2 quits amid reports of previous consulting work for Big Pharma
The U.S. Drug Enforcement Administration’s second-in-command has quietly stepped down amid reporting by The Associated Press that he previously consulted for a pharmaceutical distributor sanctioned for a deluge of suspicious painkiller shipments and di…